Reckitt Sales Drop 21% as US Demand Falls and Middle East Supply Issues

Reckitt's sales growth slowed in the first quarter. This is worse than expected and follows a 21% drop in share price this year.
By Newsroom | Business, Global Markets |

Reckitt Benckiser Group Plc saw its first-quarter sales fall short of expectations, primarily due to sluggish demand for its cold and flu remedies in the United States. The company's sales figures were also impacted by supply chain disruptions in the Middle East stemming from regional conflicts. This performance has contributed to a year-to-date share price decline of 21%.

Reckitt’s first-quarter sales growth has faltered, with lackluster consumer purchasing in the US for cold and flu treatments being a key factor. Compounding these domestic issues, global geopolitical tensions in the Middle East have disrupted the company's supply lines in that region.

North American and European Markets Show Mixed Signals

While overall sales in North America saw some boost from products like Lysol Laundry and Air Sanitizer, and Durex condoms performed well in China, the performance of its core markets appears uneven. The company anticipates a more balanced growth across all regions in the latter half of the year, with North America expected to rebound.

Read More: GE Aerospace Q2 Revenue Up 23.4% Driven by Strong Aftermarket

Reckitt is maintaining its full-year outlook for like-for-like net sales growth between 2% and 4%, though it acknowledges a "more challenging macroeconomic outlook." The consumer staples sector, typically seen as resilient, is facing increasing pressure. Big brands, including Reckitt's, are contending with intensified competition from more affordable private-label alternatives, a trend that gained traction during the COVID-19 pandemic.

The company is also "closely monitoring" the unfolding global tariff landscape and its potential effects on its supply chain and costs. Current assessments suggest these tariffs will have an "immaterial annualised impact" on the cost of goods sold, which Reckitt believes it can manage.

Strategic Realignments and Investor Scrutiny

Reckitt is continuing with the separation of its Essential Home division. However, the company's reliance on cost control measures to offset weak sales growth has drawn attention. Some analysts and investors express concern about Reckitt's exposure in the US market, pointing to its comparatively lower manufacturing capacity when placed against rivals like Haleon and Unilever. This situation arises as the company navigates what some see as a complex turnaround effort.

Read More: Gold Price Passes $5,000 on January 26, 2026 Due to Inflation Fears

Frequently Asked Questions

Q: Why did Reckitt's sales fall in the first quarter?
Reckitt's sales fell because people in the US bought fewer cold and flu medicines. Also, problems in the Middle East made it hard to get supplies to customers.
Q: How much have Reckitt's shares dropped this year?
Reckitt's shares have fallen by 21% so far this year. This is because of the lower sales and other business challenges.
Q: What is Reckitt's plan for the rest of the year?
Reckitt still expects sales to grow between 2% and 4% for the whole year. They think sales will get better in the second half of the year, especially in North America.
Q: Are Reckitt's products facing more competition?
Yes, big brands like Reckitt's are facing more competition. Cheaper store brands are becoming more popular, especially after the COVID-19 pandemic.
Q: What is Reckitt doing with its Essential Home division?
Reckitt is still planning to separate its Essential Home division into its own company. This is part of their strategy to change the business.